Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Oncocyte Corp (OCX)

Oncocyte Corp (OCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Wall Street - NYSE Full View
S&P Futures Tick Lower as Investors Digest Big Bank Earnings Barchart - Fri Apr 12, 4:32AM CDT

June S&P 500 E-Mini futures (ESM24) are down -0.12% this morning as market participants geared up for earnings from big U.S. banks.

ESM24 : 5,471.89s (-0.09%)
JPM : 206.13 (+1.91%)
WFC : 60.40 (+1.70%)
C : 63.65 (+0.30%)
PARA : 10.14 (-2.41%)
AAPL : 217.41 (+3.22%)
TEAM : 177.91 (+0.58%)
FAST : 62.44 (-0.64%)
VAR1.D.DX : 8.595 (-2.99%)
AMD : 156.26 (-3.67%)
INTC : 30.71 (-0.84%)
OCX : 3.00 (+1.69%)
Oncocyte Corporation to Present at the LD Micro Invitational XIII Newsfile - Thu Jun 1, 2023

Irvine, California--(Newsfile Corp. - June 1, 2023) - Oncocyte Corporation (NASDAQ: OCX) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard...

OCX : 3.00 (+1.69%)
Oncocyte to Participate at Upcoming Investor Conferences Globe Newswire - Wed Aug 3, 2022

IRVINE, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient...

OCX : 3.00 (+1.69%)
Oncocyte Announces the Appointment of John Peter Gutfreund as Independent Member of Its Board of Directors Effective July 28, 2022 Globe Newswire - Mon Aug 1, 2022

IRVINE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient...

OCX : 3.00 (+1.69%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating OncoCyte Corporation for Potential Breaches of Fiduciary Duty By Its Board of Directors PR Newswire - Thu Jul 28, 2022

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

OCX : 3.00 (+1.69%)
Oncocyte to Announce Second Quarter 2022 Financial Results Globe Newswire - Wed Jul 27, 2022

IRVINE, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient...

OCX : 3.00 (+1.69%)
Oncocyte Hosting Key Opinion Webinar on the Role of DetermaIO and the Tumor Microenvironment in Clinical Practice Globe Newswire - Wed Jun 22, 2022

IRVINE, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), is a precision diagnostics company with the mission to improve...

OCX : 3.00 (+1.69%)
Oncocyte Presents DetermaIO™ Data at ASCO 2022 Supporting the Test’s Potential to Expand the Clinical Use of Immunotherapy Globe Newswire - Thu May 26, 2022

DetermaIO identifies responders to immunotherapy among the 95% of patients with colon cancer currently ineligible for treatment based on existing...

OCX : 3.00 (+1.69%)
Oncocyte Completes Validation of TheraSure™ Transplant Monitor Test Globe Newswire - Thu May 5, 2022

Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions ...

OCX : 3.00 (+1.69%)
Oncocyte to Announce First Quarter 2022 Financial Results Globe Newswire - Thu Apr 28, 2022

IRVINE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve...

OCX : 3.00 (+1.69%)

Barchart Exclusives

Unusual Options Activity Supports Rivian (RIVN) But Infrastructure is Key Barchart - 19 minutes ago
Although RIVN stock is riding high on a major investment deal, the real beneficiary could be the EV infrastructure play. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot